Centre for Virology, Vaccinology and Therapeutics
Translational research centre (est. 2020) based at the Hong Kong Science and Technology Park focused on diagnostics, vaccines, antivirals and preclinical platforms for infectious diseases. Combines laboratory virology, human organoid models, transgenic animal models, analytical chemistry and computational screening to support discovery, preclinical evaluation and technology translation.
Industries
Nr. of Employees
medium (51-250)
Centre for Virology, Vaccinology and Therapeutics
Products
Organoid-based research platforms
Human respiratory and intestinal organoids used to model viral infection, evaluate antibody and vaccine efficacy, and support translational preclinical applications.
Licensable vaccine and therapeutic technologies
A portfolio of licensable technologies including live-attenuated systems, mucosal and RNA scaffold vaccine platforms, neutralizing antibodies and antiviral compound technologies.
Organoid-based research platforms
Human respiratory and intestinal organoids used to model viral infection, evaluate antibody and vaccine efficacy, and support translational preclinical applications.
Licensable vaccine and therapeutic technologies
A portfolio of licensable technologies including live-attenuated systems, mucosal and RNA scaffold vaccine platforms, neutralizing antibodies and antiviral compound technologies.
Services
Drug discovery and analytical services (NMR, LC–MS, computational screening)
Analytical and discovery support for small molecules, metabolomics and lipidomics, drug–target interaction studies, structure determination, purity assessment and integrated in silico–experimental screening.
Drug discovery and analytical services (NMR, LC–MS, computational screening)
Analytical and discovery support for small molecules, metabolomics and lipidomics, drug–target interaction studies, structure determination, purity assessment and integrated in silico–experimental screening.
Expertise Areas
- Vaccine development (mucosal, DNA, RNA, live attenuated)
- Antiviral and antibody therapeutics discovery
- Preclinical model development (organoids and transgenic animals)
- Diagnostic assay development and multiplex pathogen detection
Key Technologies
- Human organoid culture models (respiratory and intestinal)
- Transgenic mouse models
- Structure-based virtual screening and docking
- Nuclear magnetic resonance (NMR)